Gordon Reid Immucor Inc. BLUD-Q PAST TOP PICK Sep 09, 2009

(Top Pick Sep 10’08, Down 43%) They think the multiple will build back up. He is a buyer.

Gordon Reid

Owned

Unlock Rating

$18.310

Stock price when the opinion was issued

biotechnology pharmaceutical

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

TOP PICK

Manufactures and develops agents for testing of human blood prior to blood transfusions. A lot of this was done manually but is now done through their technology. Growing very rapidly. Strong balance sheet. ROE’s of about 25%. Long-term growth rate of about 20%.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Gordon Reid Immucor Inc. BLUD-Q PAST TOP PICK Sep 09, 2009

You might be interested:

Immucor Inc.(BLUD-Q)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Bruce Murray

The Panic-Proof Portfolio (Stockchase Research)

The Weekly Buzzing Stocks by Billy Kawasaki

Chris Blumas

Stockchase Insights